Status:
COMPLETED
Resolvin D1 Levels in Patients With Periodontitis
Lead Sponsor:
Ordu University
Conditions:
Periodontitis
Eligibility:
All Genders
30-60 years
Phase:
NA
Brief Summary
The purpose of the study was to determine the levels of Resolvin D1 (RVD1) in the gingival crevicular fluid (GCF) and saliva of the patients with periodontitis (P) and also to investigate the effects ...
Eligibility Criteria
Inclusion
- Stage 3, Grade B and generalized periodontitis patients
Exclusion
- excessive forces;
- presence of systemic diseases
- administration of non-steroidal and anti-inflammatory drugs or antibiotic therapies within the previous 6 months
- having received non-surgical periodontal treatment within the past 6 months
- allergy or sensitivity to any drug,
- pregnancy, lactation
- current and former use of tobacco.
Key Trial Info
Start Date :
July 31 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 29 2020
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT04496570
Start Date
July 31 2019
End Date
February 29 2020
Last Update
August 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ordu University
Ordu, Turkey (Türkiye), 52200